How Can Autoimmune Encephalitis Happen Without Antibodies?

Receiving a diagnosis of autoimmune encephalitis when your antibody tests are negative can be emotionally taxing and confusing. However, even when standard laboratory panels do not detect a characteristic neural antibody, the immune system may still be causing brain inflammation ^[1]. This can happen because the antibody targets an undiscovered protein ^[2], the test panel used was too narrow ^[3], the sample was drawn after immune treatments were started ^[4], or the inflammation is driven by other immune cells rather than antibodies ^[5]. Because a negative antibody test does not establish or rule out the disease, doctors must rely on the overall clinical picture, supportive test results, and the tailored exclusion of other causes ^[6].

Urgent Care Warning: Suspected autoimmune encephalitis can be a medical emergency. Seek immediate medical attention for rapidly worsening confusion, a new or prolonged seizure, inability to stay awake, severe agitation, or difficulty breathing or swallowing. Do not start or stop immune treatments based on this information without consulting your specialist.

Why an Antibody May Not Be Detected

A “seronegative” result simply means that no known, disease-associated antibody was found using the specific laboratory tests performed. It does not guarantee that an immune cause is impossible. There are several practical reasons why an antibody might not be detected:

• Undiscovered targets: Standard lab panels test for known antibodies. In research settings, experimental tests sometimes reveal that a patient’s antibodies react to brain cells even when standard panels are negative ^[2]. This suggests the involvement of proteins scientists have not yet identified, though such research tests are not routine diagnostic proof.
• Test limitations and test types: If a laboratory uses a narrow panel, it might miss less common antibodies ^[7]. Comprehensive testing often involves cell-based assays (which look for specific known targets). In some cases or specialist centers, doctors may also use tissue-based assays (which screen for antibodies attaching to brain tissue more broadly), though these can produce false positives and require expert interpretation ^{[1] [3]}.
• Testing only one fluid: Antibodies might be present only in the blood or only in the cerebrospinal fluid (CSF) (the fluid surrounding the brain and spinal cord). Testing both is highly recommended when clinically appropriate because relying on just one fluid can lead to a false negative ^[8].
• Timing of the test: If blood or CSF is drawn after a patient has received immunotherapies (like plasma exchange or steroids), the treatment may have already lowered circulating antibody levels ^{[3] [4]}. While it is ideal to collect samples before starting treatment, urgent therapy should not be delayed while waiting for testing. A negative result after treatment should be interpreted cautiously.

Other Immune Mechanisms May Contribute

Antibodies are just one part of the immune system. In some cases of seronegative autoimmune encephalitis, inflammation may be driven by different, antibody-independent mechanisms:

• T-cell mediated inflammation: T-cells are white blood cells that normally target infected or cancerous cells. Studies of brain tissue from biopsies or autopsies of some patients with seronegative encephalitis show T-cells and other immune cells present in the brain ^{[9] [5]}.
• Blood-brain barrier changes: The brain is protected by a filter called the blood-brain barrier. Research suggests that in autoimmune encephalitis, changes in this barrier may allow an increased movement of inflammatory signals or immune cells into the brain ^{[10] [11]}.

It is important to understand that these mechanisms are largely understood through specialized research and pathology. They represent possible contributors rather than mechanisms proven for every individual patient, and definitively proving one is not normally required before a doctor recommends treatment.

How Doctors Diagnose Without an Antibody

While the mechanisms above explain how seronegative autoimmune encephalitis might occur, a proposed theory is not proof of a diagnosis. Doctors must evaluate the entire clinical picture to ensure they are treating the right disease ^[1]. To evaluate a possible or probable case, they look for:

1. A compatible clinical syndrome: A subacute (rapid) onset of memory loss, confusion, psychiatric changes, or seizures ^[6].
2. Supportive test findings: Doctors look for supportive evidence on an MRI, a spinal tap (CSF analysis), or an EEG (brain wave test). While an EEG does not directly show inflammation, it can confirm encephalopathy or seizures. Importantly, MRI and CSF results can be normal or nonspecific in autoimmune encephalitis; normal tests do not necessarily rule out the diagnosis ^[1].
3. Evaluating alternative causes: A tailored clinical evaluation must rigorously assess for “mimics”—conditions that look similar but require different treatments. This evaluation often considers brain infections, toxic or metabolic problems, medication effects, neurodegenerative diseases, cancer-associated (paraneoplastic) disorders, and primary psychiatric illnesses ^{[6] [12]}. (Note that while seizures are a feature of autoimmune encephalitis, doctors must carefully distinguish them from non-inflammatory epilepsy).